Approval for eliminating the test redundancy by using only the bioradlyphocheck immunoassay plus controls in in-process component testing, post-fill testing and final kit combination testing for the assessment of immulite afp, free psa, and psa/3rd generation psa assay performance.
| Device | IMMULITE FPSA ASSAY |
| Classification Name | Test, Prostate Specific Antigen, Free, (noncomplexed) To Distinguish Prostate Cancer From Benign Conditions |
| Generic Name | Test, Prostate Specific Antigen, Free, (noncomplexed) To Distinguish Prostate Cancer From Benign Conditions |
| Applicant | SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS LIMITED |
| Date Received | 2012-05-30 |
| Decision Date | 2012-11-08 |
| PMA | P060005 |
| Supplement | S008 |
| Product Code | MTG |
| Advisory Committee | Immunology |
| Supplement Type | 135 Review Track For 30-day Notice |
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS LIMITED glyn Rhonwy. Llanberis caernarfon gwynedd, Ll55 4EL |
Supplemental Filings
| Supplement Number | Date | Supplement Type |
|---|
| P060005 | | Original Filing |
| S016 |
2022-09-15 |
30-day Notice |
| S015 | | |
| S014 |
2022-02-28 |
30-day Notice |
| S013 |
2021-04-14 |
30-day Notice |
| S012 |
2020-08-12 |
30-day Notice |
| S011 |
2020-07-23 |
30-day Notice |
| S010 |
2019-11-25 |
30-day Notice |
| S009 |
2018-09-28 |
Real-time Process |
| S008 |
2012-05-30 |
135 Review Track For 30-day Notice |
| S007 |
2011-12-19 |
135 Review Track For 30-day Notice |
| S006 |
2011-08-16 |
30-day Notice |
| S005 |
2011-08-08 |
30-day Notice |
| S004 |
2011-02-18 |
Real-time Process |
| S003 |
2009-11-02 |
Normal 180 Day Track No User Fee |
| S002 | | |
| S001 |
2008-11-10 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices